Search | CADTH

Showing 71 - 80 results of 3591

Ibrutinib (Imbruvica) for Lymphoma (Imbruvica) (Last Updated: Jul 17, 2019)

Project Line:

Reimbursement Review

Project Status:

Not filed

Contains:

Brand Name Manufacturer Submission Type Indication

Ibrutinib (Imbruvica) for Leukemia (Imbruvica) (Last Updated: Jul 17, 2019)

Project Line:

Reimbursement Review

Contains:

Brand Name Manufacturer Submission Type Indication

Vital Pulp Therapy for Endodontic Treatment of Mature Teeth: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines (Last Updated: Jul 10, 2019)

Project Line:

Health Technology Review

Project Status:

Completed

Thrombolytics for Acute Myocardial Infarction in a Prehospital Setting: A Review of Comparative Safety, and Guidelines (Last Updated: Jul 9, 2019)

Project Line:

Health Technology Review

Project Status:

Completed

Intra-Articular Hyaluronic Acid for Osteoarthritis of the Hip or Ankle: A Review of Clinical Effectiveness (Last Updated: Jul 11, 2019)

Project Line:

Health Technology Review

Pelvic Binders for Patients with Suspected Fracture in the Pre-Hospital Setting: Clinical Effectiveness and Guidelines (Last Updated: Jul 11, 2019)

Project Line:

Reference List

Project Status:

Completed

Midostaurin (Rydapt) for Systemic Mastocytosis (Rydapt) (Last Updated: Apr 20, 2020)

Project Line:

Reimbursement Review

Project Status:

Complete

Contains:

Brand Name Manufacturer Submission Type Indication

Interventions for the Diagnosis of Lyme Disease: Clinical Effectiveness and Guidelines (Last Updated: Jul 12, 2019)

Project Line:

Reference List

Project Status:

Completed

Timing of Pain Reassessment Post-Pharmacological Treatment Administration in Hospitals: Guidelines (Last Updated: Aug 2, 2019)

Project Line:

Reference List

Project Status:

Completed

Live Virus Vaccination in Hospital, Hospice, Nursing Home, and Long-Term Care Settings: Guidelines (Last Updated: Aug 8, 2019)

Project Line:

Reference List

CADTH | Search

Current Filters

Ibrutinib (Imbruvica) for Lymphoma (Imbruvica) (Last Updated: Jul 17, 2019)

Ibrutinib (Imbruvica) for Leukemia (Imbruvica) (Last Updated: Jul 17, 2019)

Vital Pulp Therapy for Endodontic Treatment of Mature Teeth: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines (Last Updated: Jul 10, 2019)

Thrombolytics for Acute Myocardial Infarction in a Prehospital Setting: A Review of Comparative Safety, and Guidelines (Last Updated: Jul 9, 2019)

Intra-Articular Hyaluronic Acid for Osteoarthritis of the Hip or Ankle: A Review of Clinical Effectiveness (Last Updated: Jul 11, 2019)

Pelvic Binders for Patients with Suspected Fracture in the Pre-Hospital Setting: Clinical Effectiveness and Guidelines (Last Updated: Jul 11, 2019)

Midostaurin (Rydapt) for Systemic Mastocytosis (Rydapt) (Last Updated: Apr 20, 2020)

Interventions for the Diagnosis of Lyme Disease: Clinical Effectiveness and Guidelines (Last Updated: Jul 12, 2019)

Timing of Pain Reassessment Post-Pharmacological Treatment Administration in Hospitals: Guidelines (Last Updated: Aug 2, 2019)

Live Virus Vaccination in Hospital, Hospice, Nursing Home, and Long-Term Care Settings: Guidelines (Last Updated: Aug 8, 2019)